Jos Journal of Medicine

Log in or Register to get access to full text downloads.

Remember me or Register

Use of fibroscan in assessment of hepatic fibrosis in patients with chronic hepatitis B infection

O.A. Ameh, P.M. Davwar, M.J. Duguru, C.M. Okorie, K Zawaya, N.P. David, E.N. Okeke


Introduction: Assessment of the stage of liver fibrosis plays a prominent role in the decision process of treatment in chronic viral hepatitis.

Objective: To determine the stage of fibrosis in patients with chronic HBV infection using fibroscan.

Method: This is a cross sectional descriptive study involving patients with CHB with a valid transient elastography (TE) measurement. Liver function test and platelet count was determined. APRI and FIB-4 were calculated and Spermans rank coefficient was applied for correlation of transient elastography (TE) with either serum biomarkers.

Results: 190 patients were enrolled, mean age 36.3years, 64.2% males and 89.9% were asymptomatic. TE correlated significantly with APRI and FIB-4 (r = 0.58; P < 0.001 and r = 0.42; P < 0.001, respectively). Most of the patients 131(68.9%) had no significant fibrosis (F0,F1) while those with significant fibrosis and cirrhosis were 59 (31.1%) and 23(12.1%) respectively.

Conclusion: The prevalence of significant fibrosis and cirrhosis is high in this population.

Keywords: Fibroscan, Hepatic fibrosis, APRI, FIB-4

AJOL African Journals Online